title: [Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders].
mesh_terms: D000109:Acetylcholine / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000588:Amines / Q000627:therapeutic use*; D000804:Angiotensin II / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003981:Diazoxide / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D007610:Kallikreins / Q000627:therapeutic use; D008053:Lipid Mobilization / Q000187:drug effects; D008750:Methyldopa / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010293:Pargyline / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011437:Propylamines / Q000627:therapeutic use; D011526:Protoveratrines / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D011926:Rauwolfia / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use*; D014020:Tissue Extracts / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D000588:Amines; D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D004876:Ergot Alkaloids; D009539:Nicotinic Acids; D010276:Parasympatholytics; D010627:Phenethylamines; D011437:Propylamines; D011526:Protoveratrines; D011687:Purines; D013565:Sympatholytics; D013566:Sympathomimetics; D014020:Tissue Extracts; D014665:Vasodilator Agents; D000804:Angiotensin II; D008750:Methyldopa; D000255:Adenosine Triphosphate; D010293:Pargyline; D007610:Kallikreins; D000109:Acetylcholine; D003981:Diazoxide
vernacular_title: Angiotika. 48. I. Hypertensiva. II. Hypotensiva. 3. Vasodilatantien. IV. Stoffe zur Behandlung von Lipidstoffwechselstörungen.